Pegylated-interferon alpha 2a treatment for chronic hepatitis C in patients on chronic haemodialysis. (Q33371890)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16830372%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

title

Pegylated-interferon alpha 2a treatment for chronic hepatitis C in patients on chronic haemodialysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16830372%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

1 reference

1 reference

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16830372%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

author name string

Ioan Sporea

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16830372%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Alina Popescu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16830372%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Ovidiu Golea

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16830372%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Camelia Totolici

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16830372%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Mirela Danila

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16830372%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Corina Vernic

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16830372%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

language of work or name

English

0 references

publication date

1 July 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16830372%20AND%20SRC:MED&resulttype=core&format=json

World Journal of Gastroenterology

26 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16830372%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16830372%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

issue

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16830372%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

page(s)

4191-4194

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16830372%20AND%20SRC:MED&resulttype=core&format=json

European study on epidemiology and the management of HCV in the haemodialysis population--Part 1: centre policy

26 December 2019

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087371

Confirmation of nosocomial hepatitis C virus infection in a hemodialysis unit

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087371

Meta-analysis: interferon for the treatment of chronic hepatitis C in dialysis patients

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087371

Evidence that clearance of hepatitis C virus RNA after alpha-interferon therapy in dialysis patients is sustained after renal transplantation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087371

National surveillance of dialysis-associated diseases in the United States, 2000.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087371

Hepatitis C infection and the patient with end-stage renal disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087371

Treatment of hepatitis C virus infection after renal transplantation: new insights

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087371

Hepatitis C virus infections in dialysis centers in The Netherlands: a national survey by serological and molecular methods

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087371

Universal precautions prevent hepatitis C virus transmission: a 54 month follow-up of the Belgian Multicenter Study. The Universitaires Cliniques St-Luc (UCL) Collaborative Group

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087371

High rate of hepatitis C virus clearance in hemodialysis patients after interferon-alpha therapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087371

Impact of dialysis room and reuse strategies on the incidence of hepatitis C virus infection in haemodialysis units

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087371

Treatment of chronic hepatitis C with recombinant interferon alpha in kidney transplant recipients

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087371

Interferon-alpha-induced acute renal allograft rejection

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087371

Mode of hepatitis C infection not associated with blood transfusion among chronic hemodialysis patients

21 June 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I26.4191

Incidence of HCV infection in French hemodialysis units: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I26.4191

Histopathological features of hepatitis C in renal transplant candidates [see comment]

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I26.4191

Long-term ribavirin therapy in hepatitis C virus-positive renal transplant patients: effects on renal function and liver histology

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I26.4191

Safety of interferon and ribavirin therapy in haemodialysis patients with chronic hepatitis C: results of a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I26.4191

Ribavirin treatment in dialysis patients with chronic hepatitis C virus infection--a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I26.4191

Sustained virological and histological response with pretransplant interferon therapy in renal transplant patients with chronic viral hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I26.4191

Prevalence of hepatitis C antibodies among hemodialysis patients in Al-hasa region of saudi arabia.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087371

Superiority of standard interferon-alpha2b compared to pegylated interferon-alpha2b (12 kDa) in a hemodialysis patient with chronic hepatitis C?

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087371

Hepatitis C virus infection in French hemodialysis units: a multicenter study

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087371

Results of a national epidemiological investigation on HCV infection among dialysis patients. (Survey by the Italian Branch of EDTNA/ERCA).

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087371

Randomized trial of pegylated interferon alpha-2b monotherapy in haemodialysis patients with chronic hepatitis C

31 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16830372

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Interferon therapy in hemodialysis patients with chronic hepatitis C: study of tolerance, efficacy and post-transplantation course

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16830372

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

[HCV RNA clearance after treatment with interferon-alpha in chronic hemodialysis patients with or without coinfection by HGV/HGBV-C]

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16830372

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.3748/WJG.V12.I26.4191

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16830372%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16830372%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16830372%20AND%20SRC:MED&resulttype=core&format=json